Rifampicin is a broad-spectrum antibiotic

Asia Bio-Pharmaceutical Research Institute
Submitted by xulijin on Wed, 09/18/2019 - 02:52

Rifampicin has antibacterial or bactericidal effects against Mycobacterium tuberculosis, Gram-positive bacteria and some Gram-negative bacteria. Rifampicin is mainly used for the infection of drug-resistant tuberculosis and drug-resistant Staphylococcus aureus, and has a certain effect on leprosy.
Rifampicin has antibacterial or bactericidal effects against Mycobacterium tuberculosis, Gram-positive bacteria and some Gram-negative bacteria. Rifampicin is mainly used for the infection of drug-resistant tuberculosis and drug-resistant Staphylococcus aureus, and has a certain effect on leprosy. It is a broad-spectrum antibiotic and can enter the cell. It is a full-effect bactericidal drug. It is a broad-spectrum antibiotic with strong bactericidal power. It has strong bactericidal action against both bacillus and Gram-positive and negative bacteria. It has a broad-spectrum antibacterial effect as a pharmaceutical intermediate. It has good antibacterial activity against Gram-positive cocci and Mycobacterium tuberculosis.